Reports for NALOXONE HCL INJECTION - 1MG/ML USP
Brand name
NALOXONE HCL INJECTION - 1MG/ML USP
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02148714 |
Ingredients
NALOXONE HYDROCHLORIDE |
Ingredient Strength
1 MG |
ATC Code
V03ABV03AB |
ATC Descriptor
ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
NALOXONE HCL INJECTION - 1MG/ML USP | 10x2mL fioles/vials | Resolved | 2017-03-14 | 2017-06-26 | 2609 |
NALOXONE HCL INJECTION - 1MG/ML USP | 10X2ml | Resolved | 2019-04-05 | 2019-06-28 | 80573 |
NALOXONE HCL INJECTION - 1MG/ML USP | 10LIVI CA | Resolved | 2020-12-07 | 2021-02-16 | 129727 |
NALOXONE HCL INJECTION - 1MG/ML USP | 2ML | Resolved | 2022-10-19 | 2022-12-29 | 172174 |
NALOXONE HCL INJECTION - 1MG/ML USP | 2ML | Resolved | 2023-01-19 | 2023-03-21 | 181704 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0